jaggu

Seattle Genetics SGEN

Long
NASDAQ:SGEN   None
Earnings next week will spike Seattle Genetics, given its history for last several quarters of beating the estimate. If the whole market drops due to some international jitters like Crimea, etc, SGEN may fall a bit , but has solid support at 31.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.